Updated:
Codman Neuro
Codman Neuro, a subsidiary of DePuy Synthes Companies of Johnson & Johnson, specializes in neurosurgery and neurovascular devices. Its portfolio includes...
Codman Neuro
Codman Neuro, a subsidiary of DePuy Synthes Companies of Johnson & Johnson, specializes in neurosurgery and neurovascular devices. Its portfolio includes products for hydrocephalus management, neuro intensive care, and cranial surgery. The company also offers aneurysm coils and vascular reconstruction devices for endovascular treatment of cerebral aneurysms and stroke.
General information
Firm type
Neurosurgery
Year founded
1838
Location
Region
North America
Country
United States
City
Raynham
Corporate office
Raynham, MA, United States
Sector focus
Frequently asked questions
What is Codman Neuro?
Codman Neuro is a neurosurgery headquartered in Raynham, United States.
When was Codman Neuro founded?
Codman Neuro was founded in 1838.
Where is Codman Neuro headquartered?
Codman Neuro is headquartered in Raynham, United States, in the North America region.
What does Altss track for Codman Neuro?
Altss maintains an OSINT-verified profile of Codman Neuro covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.
What type of firm is Codman Neuro?
Codman Neuro is classified by Altss as a Neurosurgery, operating from United States within the North America region.
How does Altss source intelligence on Codman Neuro?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
When was Codman Neuro's Altss profile last updated?
Codman Neuro's profile on Altss was last refreshed on August 10, 2026. Continuous updates are applied as new public information is verified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: